AR013096A1 - SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME. - Google Patents
SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME.Info
- Publication number
- AR013096A1 AR013096A1 ARP980102925A ARP980102925A AR013096A1 AR 013096 A1 AR013096 A1 AR 013096A1 AR P980102925 A ARP980102925 A AR P980102925A AR P980102925 A ARP980102925 A AR P980102925A AR 013096 A1 AR013096 A1 AR 013096A1
- Authority
- AR
- Argentina
- Prior art keywords
- tetrazol
- methyl
- preparation
- maleic acid
- tetrahidropiridina
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Sal de adicion de ácido maleico de 5-(2-etil-2-H-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahdropiridina, composiciones farmacéuticas que contienen la sal deadicion ácida, el uso de las mismas para el tratamiento de trastornos causados por unmal funcionamiento de la acetilcolina (AcCh) o del sistemamuscarínico; y método de preparacion de la misma.5- (2-Ethyl-2-H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahdropyridine maleic acid addition salt, pharmaceutical compositions containing the acidic salt, use thereof for the treatment of disorders caused by a malfunction of acetylcholine (AcCh) or the muscarinic system; and method of preparation thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013096A1 true AR013096A1 (en) | 2000-12-13 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102925A AR013096A1 (en) | 1997-07-01 | 1998-06-18 | SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (en) |
| JP (1) | JP2002507215A (en) |
| KR (1) | KR20010014297A (en) |
| CN (1) | CN1261361A (en) |
| AR (1) | AR013096A1 (en) |
| AU (1) | AU735751B2 (en) |
| BG (1) | BG103933A (en) |
| BR (1) | BR9810331A (en) |
| CA (1) | CA2293324A1 (en) |
| CO (1) | CO4940483A1 (en) |
| EA (1) | EA200000081A1 (en) |
| HU (1) | HUP0002876A2 (en) |
| IL (1) | IL133093A0 (en) |
| IS (1) | IS5278A (en) |
| JO (1) | JO2031B1 (en) |
| MA (1) | MA25138A1 (en) |
| NO (1) | NO996580L (en) |
| PE (1) | PE116099A1 (en) |
| PL (1) | PL337184A1 (en) |
| SK (1) | SK187399A3 (en) |
| TN (1) | TNSN98120A1 (en) |
| TR (1) | TR199903283T2 (en) |
| UY (2) | UY25069A1 (en) |
| WO (1) | WO1999001448A1 (en) |
| ZA (1) | ZA985498B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| CZ287441B6 (en) * | 1995-11-06 | 2000-11-15 | Lundbeck & Co As H | Pharmaceutical preparation for treating traumatic lesion of brain |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU735751B2 (en) | 2001-07-12 |
| EA200000081A1 (en) | 2000-08-28 |
| PL337184A1 (en) | 2000-08-14 |
| TR199903283T2 (en) | 2000-06-21 |
| JP2002507215A (en) | 2002-03-05 |
| BR9810331A (en) | 2000-09-05 |
| CA2293324A1 (en) | 1999-01-14 |
| ZA985498B (en) | 1999-01-20 |
| CO4940483A1 (en) | 2000-07-24 |
| UY25177A1 (en) | 2000-12-29 |
| NO996580D0 (en) | 1999-12-30 |
| SK187399A3 (en) | 2000-06-12 |
| PE116099A1 (en) | 1999-11-23 |
| UY25069A1 (en) | 1998-12-21 |
| CN1261361A (en) | 2000-07-26 |
| NO996580L (en) | 1999-12-30 |
| MA25138A1 (en) | 2001-04-02 |
| HUP0002876A2 (en) | 2001-06-28 |
| EP0994869A1 (en) | 2000-04-26 |
| JO2031B1 (en) | 1999-05-15 |
| WO1999001448A1 (en) | 1999-01-14 |
| BG103933A (en) | 2000-07-31 |
| TNSN98120A1 (en) | 2005-03-15 |
| IL133093A0 (en) | 2001-03-19 |
| IS5278A (en) | 1999-11-30 |
| AU8102098A (en) | 1999-01-25 |
| KR20010014297A (en) | 2001-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2146300T3 (en) | USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS. | |
| EP0727215A3 (en) | Central cholecystokinin antagonists for the treatment of psychiatric diseases | |
| ES2150496T3 (en) | CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS. | |
| MY128654A (en) | Liquid pharmaceutical composition containing an erythropoietin derivative | |
| ATE225341T1 (en) | PACLITAXELE SUBSTITUTED BY THIO IN 6 POSITION | |
| DK0413528T3 (en) | Amphoteric preparations and polymeric forms of alpha hydroxy acids and their therapeutic use | |
| BR9714517A (en) | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds | |
| DK0495982T3 (en) | Bicyclic pyrimidine derivative, process for its preparation and pharmaceutical composition comprising this as an active ingredient | |
| BG101118A (en) | Therapeutical compounds | |
| BRPI0007487B8 (en) | diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors | |
| BR9714059A (en) | S-omeprazole in a neutral form, process to prepare it, use of it, pharmaceutical composition, and process to treat a condition related to gastric acid. | |
| BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
| ES2149276T3 (en) | IMIDAZO (4,5-C) PIRIDIN-4-AMINAS. | |
| MX9202407A (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION. | |
| CU23260B7 (en) | MOXIFLOXACINE PHARMACEUTICAL PREPARATION | |
| PT100850A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A SYNERGY MIX OF A URICOSURIC AGENT, IN PARTICULAR, OF PROBENECID, WITH AN ANTAGONIST AGENT OF AMINOACIDES EXCITING, ESPECIALLY, A DERIVATIVE OF SUBSTITUTED CHINOXALINE AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| KR870700599A (en) | Carboxylic acid derivatives, methods for their preparation, pharmaceutical compositions containing these compounds and uses thereof | |
| FI972308A0 (en) | 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions containing them and methods for their use | |
| BR0009524A (en) | Use of a compound, and, pharmaceutical or veterinary composition | |
| BRPI0409884A (en) | compounds, pharmaceutical compositions, method for treating or porphyxia of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
| EP0974363A4 (en) | Remedies for drug addiction | |
| BR9809234A (en) | Compound, pharmaceutical composition, use of a compound, processes to treat or prevent diseases of the endocrinological system, to manufacture a drug, to prepare a compound and a set, and use of it. | |
| BRPI0409818A (en) | compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds | |
| AR013096A1 (en) | SALE OF ADDITION OF MALEIC ACID OF 5- (2-ETIL-2-H-TETRAZOL-5-IL) -1-METHYL-1,2,3,6-TETRAHIDROPIRIDINA, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT, ITS USE IN THERAPY AND METHOD OF PREPARATION OF THE SAME. | |
| BR0011845A (en) | Pharmaceutical complex |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |